Shuttle Pharmaceuticals Holdings (SHPH) Shares Issued (2021 - 2025)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Shares Issued came in at $69066.0 in Q2 2025, down 50.04% year-on-year from $138234.0 in Q2 2024, and down 96.0% quarter-over-quarter from $1.7 million in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Shares Issued (2021 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Shares Issued history runs 5 years deep, the most recent figure standing at $69066.0 for Q2 2025.
- On a quarterly basis, Shares Issued fell 50.04% year-over-year to $69066.0 in Q2 2025; TTM through Jun 2025 was $69066.0, a 50.04% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, up 1285.58% from the prior year.
- Shares Issued retreated to $69066.0 in Q2 2025 per SHPH's latest filing, from $1.7 million in the prior quarter.
- Across five years, Shares Issued topped out at $1.7 million in Q1 2025 and bottomed at $59182.0 in Q3 2022.
- The 5-year median for Shares Issued is $117753.5 (2024), against an average of $397206.7.
- Across the five-year window, Shares Issued sank 79.8% in 2023 and surged 1473.41% in 2025, its largest moves.
- Year by year, Shares Issued stood at $63686.0 in 2021, then jumped by 559.1% to $419754.0 in 2022, then sank by 79.8% to $84779.0 in 2023, then surged by 1285.58% to $1.2 million in 2024, then tumbled by 94.12% to $69066.0 in 2025.
- Per Business Quant, the three latest SHPH Shares Issued figures stand at $69066.0 (Q2 2025), $1.7 million (Q1 2025), and $1.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 69,066.00 |
| Jun 30, 2025 | 69,066.00 |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 125,734.00 |
| Sep 30, 2024 | 125,734.00 |
| Jun 30, 2024 | 138,234.00 |
| Jun 30, 2024 | 138,234.00 |
| Mar 31, 2024 | 109,773.00 |
| Mar 31, 2024 | 109,773.00 |
| Dec 31, 2023 | 84,779.00 |
| Dec 31, 2023 | 84,779.00 |
| Dec 31, 2022 | 419,754.00 |
| Dec 31, 2022 | 419,754.00 |
| Sep 30, 2022 | 59,182.00 |
| Sep 30, 2022 | 59,182.00 |
| Dec 31, 2021 | 63,686.00 |
| Dec 31, 2021 | 63,686.00 |